BIO.B · Company research
Bio-Rad Laboratories, Inc. Class B (BIO.B): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 365.08 | $9,803,128,160 | 9286128160.00 | 16.480678945467677 | — | 0.882245519695449 | 15.0585686021505376 | 1.3664991371499463 | 150.3547263803680968 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.